 | • レポートコード：MRC2-11QY03644 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカナバン病治療薬のグローバル市場について調査・分析したレポートです。種類別（遺伝子治療、組換え酵素、TUR-007、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カナバン病治療薬の競争状況、市場シェア ・世界のカナバン病治療薬市場：種類別市場規模 2015年-2020年（遺伝子治療、組換え酵素、TUR-007、その他） ・世界のカナバン病治療薬市場：種類別市場規模予測 2021年-2026年（遺伝子治療、組換え酵素、TUR-007、その他） ・世界のカナバン病治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のカナバン病治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のカナバン病治療薬市場分析：米国、カナダ ・ヨーロッパのカナバン病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカナバン病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカナバン病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカナバン病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc、Turing Pharmaceuticals AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Canavan Disease Therapeutics Market
The global Canavan Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Canavan Disease Therapeutics Scope and Market Size
Canavan Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Canavan Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Canavan Disease Therapeutics market is segmented into
Gene Therapy
Recombinant Enzyme
TUR-007
Others
Segment by Application, the Canavan Disease Therapeutics market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Canavan Disease Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Canavan Disease Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Canavan Disease Therapeutics Market Share Analysis
Canavan Disease Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Canavan Disease Therapeutics business, the date to enter into the Canavan Disease Therapeutics market, Canavan Disease Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Turing Pharmaceuticals AG
…
1 Study Coverage
1.1 Canavan Disease Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Canavan Disease Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Canavan Disease Therapeutics Market Size Growth Rate by Type
1.4.2 Gene Therapy
1.4.3 Recombinant Enzyme
1.4.4 TUR-007
1.4.5 Others
1.5 Market by Application
1.5.1 Global Canavan Disease Therapeutics Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Canavan Disease Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Canavan Disease Therapeutics Revenue 2015-2026
2.1.2 Global Canavan Disease Therapeutics Sales 2015-2026
2.2 Global Canavan Disease Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Canavan Disease Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Canavan Disease Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Canavan Disease Therapeutics Competitor Landscape by Players
3.1 Canavan Disease Therapeutics Sales by Manufacturers
3.1.1 Canavan Disease Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Canavan Disease Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Canavan Disease Therapeutics Revenue by Manufacturers
3.2.1 Canavan Disease Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Canavan Disease Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Canavan Disease Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Canavan Disease Therapeutics Revenue in 2019
3.2.5 Global Canavan Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Canavan Disease Therapeutics Price by Manufacturers
3.4 Canavan Disease Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Canavan Disease Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Canavan Disease Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Canavan Disease Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Canavan Disease Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Canavan Disease Therapeutics Sales by Type (2015-2020)
4.1.2 Global Canavan Disease Therapeutics Revenue by Type (2015-2020)
4.1.3 Canavan Disease Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Canavan Disease Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Canavan Disease Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Canavan Disease Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Canavan Disease Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Canavan Disease Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Canavan Disease Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Canavan Disease Therapeutics Sales by Application (2015-2020)
5.1.2 Global Canavan Disease Therapeutics Revenue by Application (2015-2020)
5.1.3 Canavan Disease Therapeutics Price by Application (2015-2020)
5.2 Canavan Disease Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Canavan Disease Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Canavan Disease Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Canavan Disease Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Canavan Disease Therapeutics by Country
6.1.1 North America Canavan Disease Therapeutics Sales by Country
6.1.2 North America Canavan Disease Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Canavan Disease Therapeutics Market Facts & Figures by Type
6.3 North America Canavan Disease Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Canavan Disease Therapeutics by Country
7.1.1 Europe Canavan Disease Therapeutics Sales by Country
7.1.2 Europe Canavan Disease Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Canavan Disease Therapeutics Market Facts & Figures by Type
7.3 Europe Canavan Disease Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Canavan Disease Therapeutics by Region
8.1.1 Asia Pacific Canavan Disease Therapeutics Sales by Region
8.1.2 Asia Pacific Canavan Disease Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Canavan Disease Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Canavan Disease Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Canavan Disease Therapeutics by Country
9.1.1 Latin America Canavan Disease Therapeutics Sales by Country
9.1.2 Latin America Canavan Disease Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Canavan Disease Therapeutics Market Facts & Figures by Type
9.3 Central & South America Canavan Disease Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Canavan Disease Therapeutics by Country
10.1.1 Middle East and Africa Canavan Disease Therapeutics Sales by Country
10.1.2 Middle East and Africa Canavan Disease Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Canavan Disease Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Canavan Disease Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Canavan Disease Therapeutics Products Offered
11.1.5 Pfizer Inc Related Developments
11.2 Turing Pharmaceuticals AG
11.2.1 Turing Pharmaceuticals AG Corporation Information
11.2.2 Turing Pharmaceuticals AG Description and Business Overview
11.2.3 Turing Pharmaceuticals AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Turing Pharmaceuticals AG Canavan Disease Therapeutics Products Offered
11.2.5 Turing Pharmaceuticals AG Related Developments
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Canavan Disease Therapeutics Products Offered
11.1.5 Pfizer Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Canavan Disease Therapeutics Market Estimates and Projections by Region
12.1.1 Global Canavan Disease Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Canavan Disease Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Canavan Disease Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Canavan Disease Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Canavan Disease Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Canavan Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Canavan Disease Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Canavan Disease Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Canavan Disease Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Canavan Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Canavan Disease Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Canavan Disease Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Canavan Disease Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Canavan Disease Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Canavan Disease Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Canavan Disease Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Canavan Disease Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Canavan Disease Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Canavan Disease Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Canavan Disease Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Canavan Disease Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Canavan Disease Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Canavan Disease Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Canavan Disease Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Canavan Disease Therapeutics Market Segments
Table 2. Ranking of Global Top Canavan Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Canavan Disease Therapeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Gene Therapy
Table 5. Major Manufacturers of Recombinant Enzyme
Table 6. Major Manufacturers of TUR-007
Table 7. Major Manufacturers of Others
Table 8. Global Canavan Disease Therapeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Canavan Disease Therapeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Canavan Disease Therapeutics Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Canavan Disease Therapeutics Sales Market Share by Regions (2015-2020)
Table 12. Global Canavan Disease Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Canavan Disease Therapeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Canavan Disease Therapeutics Sales Share by Manufacturers (2015-2020)
Table 15. Global Canavan Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Canavan Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canavan Disease Therapeutics as of 2019)
Table 17. Canavan Disease Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Canavan Disease Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Canavan Disease Therapeutics Price (2015-2020) (USD/Pcs)
Table 20. Canavan Disease Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Canavan Disease Therapeutics Product Type
Table 22. Date of International Manufacturers Enter into Canavan Disease Therapeutics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 25. Global Canavan Disease Therapeutics Sales Share by Type (2015-2020)
Table 26. Global Canavan Disease Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Canavan Disease Therapeutics Revenue Share by Type (2015-2020)
Table 28. Canavan Disease Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 30. Global Canavan Disease Therapeutics Sales Share by Application (2015-2020)
Table 31. North America Canavan Disease Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 32. North America Canavan Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 33. North America Canavan Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Canavan Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 35. North America Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 36. North America Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 37. North America Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 38. North America Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 39. Europe Canavan Disease Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Canavan Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 41. Europe Canavan Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Canavan Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 43. Europe Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 45. Europe Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Canavan Disease Therapeutics Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Canavan Disease Therapeutics Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Canavan Disease Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Canavan Disease Therapeutics Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 55. Latin America Canavan Disease Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Canavan Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Canavan Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Canavan Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 59. Latin America Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Latin America Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Canavan Disease Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Canavan Disease Therapeutics Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Canavan Disease Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Canavan Disease Therapeutics Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Canavan Disease Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Canavan Disease Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Table 71. Pfizer Inc Corporation Information
Table 72. Pfizer Inc Description and Major Businesses
Table 73. Pfizer Inc Canavan Disease Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Pfizer Inc Product
Table 75. Pfizer Inc Recent Development
Table 76. Turing Pharmaceuticals AG Corporation Information
Table 77. Turing Pharmaceuticals AG Description and Major Businesses
Table 78. Turing Pharmaceuticals AG Canavan Disease Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Turing Pharmaceuticals AG Product
Table 80. Turing Pharmaceuticals AG Recent Development
Table 81. Global Canavan Disease Therapeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 82. Global Canavan Disease Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 83. Global Canavan Disease Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 84. Global Canavan Disease Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 85. North America: Canavan Disease Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 86. North America: Canavan Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 87. Europe: Canavan Disease Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 88. Europe: Canavan Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 89. Asia Pacific: Canavan Disease Therapeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 90. Asia Pacific: Canavan Disease Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 91. Latin America: Canavan Disease Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. Latin America: Canavan Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Middle East and Africa: Canavan Disease Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Middle East and Africa: Canavan Disease Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 96. Key Challenges
Table 97. Market Risks
Table 98. Main Points Interviewed from Key Canavan Disease Therapeutics Players
Table 99. Canavan Disease Therapeutics Customers List
Table 100. Canavan Disease Therapeutics Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Canavan Disease Therapeutics Product Picture
Figure 2. Global Canavan Disease Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Gene Therapy Product Picture
Figure 4. Recombinant Enzyme Product Picture
Figure 5. TUR-007 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Canavan Disease Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Others
Figure 11. Canavan Disease Therapeutics Report Years Considered
Figure 12. Global Canavan Disease Therapeutics Market Size 2015-2026 (US$ Million)
Figure 13. Global Canavan Disease Therapeutics Sales 2015-2026 (K Pcs)
Figure 14. Global Canavan Disease Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Canavan Disease Therapeutics Sales Market Share by Region (2015-2020)
Figure 16. Global Canavan Disease Therapeutics Sales Market Share by Region in 2019
Figure 17. Global Canavan Disease Therapeutics Revenue Market Share by Region (2015-2020)
Figure 18. Global Canavan Disease Therapeutics Revenue Market Share by Region in 2019
Figure 19. Global Canavan Disease Therapeutics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Canavan Disease Therapeutics Revenue in 2019
Figure 21. Canavan Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Canavan Disease Therapeutics Sales Market Share by Type (2015-2020)
Figure 23. Global Canavan Disease Therapeutics Sales Market Share by Type in 2019
Figure 24. Global Canavan Disease Therapeutics Revenue Market Share by Type (2015-2020)
Figure 25. Global Canavan Disease Therapeutics Revenue Market Share by Type in 2019
Figure 26. Global Canavan Disease Therapeutics Market Share by Price Range (2015-2020)
Figure 27. Global Canavan Disease Therapeutics Sales Market Share by Application (2015-2020)
Figure 28. Global Canavan Disease Therapeutics Sales Market Share by Application in 2019
Figure 29. Global Canavan Disease Therapeutics Revenue Market Share by Application (2015-2020)
Figure 30. Global Canavan Disease Therapeutics Revenue Market Share by Application in 2019
Figure 31. North America Canavan Disease Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Canavan Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Canavan Disease Therapeutics Sales Market Share by Country in 2019
Figure 34. North America Canavan Disease Therapeutics Revenue Market Share by Country in 2019
Figure 35. U.S. Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Canavan Disease Therapeutics Market Share by Type in 2019
Figure 40. North America Canavan Disease Therapeutics Market Share by Application in 2019
Figure 41. Europe Canavan Disease Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Canavan Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Canavan Disease Therapeutics Sales Market Share by Country in 2019
Figure 44. Europe Canavan Disease Therapeutics Revenue Market Share by Country in 2019
Figure 45. Germany Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Canavan Disease Therapeutics Market Share by Type in 2019
Figure 56. Europe Canavan Disease Therapeutics Market Share by Application in 2019
Figure 57. Asia Pacific Canavan Disease Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Canavan Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Canavan Disease Therapeutics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Canavan Disease Therapeutics Revenue Market Share by Region in 2019
Figure 61. China Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Canavan Disease Therapeutics Market Share by Type in 2019
Figure 84. Asia Pacific Canavan Disease Therapeutics Market Share by Application in 2019
Figure 85. Latin America Canavan Disease Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Canavan Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Canavan Disease Therapeutics Sales Market Share by Country in 2019
Figure 88. Latin America Canavan Disease Therapeutics Revenue Market Share by Country in 2019
Figure 89. Mexico Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Canavan Disease Therapeutics Market Share by Type in 2019
Figure 96. Latin America Canavan Disease Therapeutics Market Share by Application in 2019
Figure 97. Middle East and Africa Canavan Disease Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Canavan Disease Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Canavan Disease Therapeutics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Canavan Disease Therapeutics Revenue Market Share by Country in 2019
Figure 101. Turkey Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Canavan Disease Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Canavan Disease Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Canavan Disease Therapeutics Market Share by Type in 2019
Figure 108. Middle East and Africa Canavan Disease Therapeutics Market Share by Application in 2019
Figure 109. North America Canavan Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Canavan Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Canavan Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Canavan Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Canavan Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Canavan Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Canavan Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Canavan Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Canavan Disease Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Canavan Disease Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …- フォンウィルブランド病（VWD）治療薬の世界市場（～2026年） Von Willebrand Disease is an inherited bleeding disorder that is caused by deficiency or dysfunction of Von Willebrand Factor (VWF). VWF is a plasma protein that mediates the initial adhesion of platelets at sites of vascular injury. This protein also binds to clotting factor VIII (FVIII) in the cir…
- アルツハイマー病治療薬の世界市場（～2026年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…
- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…